 Thermo Fisher Scientific Inc NYSE: TMO has posted Q1 revenue of 11.82 billion, beating the consensus of 10.63 billion. Organic revenue growth was 3, acquisitions increased revenue by 18, and currency translation decreased revenue by 2. 